Summary Amplification of the CCDNI gene encoding cyclin DI was examined by Southern blotting and multiplex polymerase chain reaction (PCR) and occurred in 8 of 53 patients (15%) with primary resected nonsmall-cell lung cancer (NSCLC). These tumours and 17 additional tumours with a normal gene copy number showed overexpression of cyclin Dl (25/53, 47%), as assessed by immunostaining using a monoclonal antibody. In 22/25 cases, cyclin DI was localised in the cytoplasm, but some (7/25) had simultaneous nuclear staining. This result is in marked contrast to that reported in breast, hepatocellular and colorectal carcinoma studies where immunostaining was invariably nuclear. Examination of a restriction fragment length polymorphic (RFLP) site within the 3'untranslated region of the cDNA following reverse transcriptase (RT)-PCR (29/53 informative cases) showed a strong association between cytoplasmic staining and imbalance in allele-specific message levels. Cyclin Dl overexpression was associated with a poorly differentiated histology (P=0.04), less lymphocytic infiltration of the tumour (P=0.02) and a reduction in local relapse rate (P =0.01). The relative risk of local relapse was 9.1 in tumours without cyclin Dl overexpression (P = 0.01, Cox regression analysis). We conclude that genetic alteration of cyclin Dl is a key abnormality in lung carcinogenesis and may have diagnostic and prognostic importance in the treatment of resectable NSCLC.
Advances in molecular biology paved the way for the identification of proteins responsible for the regulation of cell proliferation. One of these molecules, cyclin Dl, is expressed during the early phase of the cell cycle, before the restriction point (START), beyond which cells are committed to enter S phase. This cyclin may act as an initiator of the cell cycle, and perhaps as a growth factor sensor (Xiong et al., 1991; Motokura and Arnold, 1993a,b; Sherr, 1993; Hunter and Pires, 1994; Marx, 1994) . The ability of cyclin Dl to immortalise cells in vitro established its oncogenic activity (Hinds et al., 1994; Lovec et al., 1994) . The cyclin Dl gene (CCNDI) is one of the most frequently amplified chromosomal regions (11 q 13) in human carcinomas (Motokura and Arnold, 1993b) . In laryngeal (Jares et al., 1994) and head and neck carcinomas Michalides et al., 1995) , its overexpression has been shown to be associated with advanced local invasion and presence of lymph node metastases. Cyclin Dl may therefore play a key role in cell growth regulation and tumorigenesis.
Lung cancer is a worldwide problem and in many countries it is the most lethal malignancy. As relapse is frequent after resection of early stage non-small-cell lung cancer (NSCLC) (Ginsberg et al., 1993) , there is an urgent need to define prognostic factors. These would help in the choice of the best therapeutic procedure (wide surgical resection, (neo-)adjuvant chemo-and/or radiotherapy) . In this study we will provide evidence that, surprisingly, cyclin DI overexpression is associated with lower local relapse risk in resectable NSCLC, despite also being associated with poor tumour differentiation, known to be a negative indicator. (Blin et al., 1976) and RNA was extracted using Dynabeads (Dynal, Oslo, Norway) (Jakobsen et al., 1990) before being reverse transcribed to cDNA (Superscript Preamplification System, Life Technologies, Paisley, UK).
Patients and methods
Southern blot analysis TaqI digests of 5 ,g of genomic DNA were blotted onto Hybond-N filter (Amersham, Buckinghamshire, England).
Purified DNA probes (CCNDJ, nt: 1100-1888 and adenosine deaminase, ADA, assigned to chromosome 20q12-13, nt: 34275 -34785) were labelled with _-32P-dCTP (Amersham) using a random-primed DNA labelling kit (Boehringer, Mannheim, Germany) and hybridised overnight to the immobilised DNA. Filters were subsequently washed for 30 min, once with 2 x SSC and once with 0.5 x SSC at 65°C and exposed to Kodak X-OMAT film at -70°C for several days. The CCNDI gene was considered amplified when the intensity of the ratio CCNDI/ADA signal (assessed by Phosphor Imager analysis, 425S, Molecular Dynamics) was increased at least 3-fold relative to the ADA gene signal, which served as an internal control for DNA loading and which was assumed not to be amplified in lung tumours. Digested DNA isolated from normal lung tissue from each patient was used as a control.
PCR
The PCR multiplex was performed as described (Edwards and Gibbs, 1994 Kaplan -Meier survivor function estimates were used and simple comparisons between the two groups were made with the log-rank test. EFS is a mixing of three types of event (Kay et al., 1983 ) and the type-specific cumulative event rates were estimated with the Nelson estimator (Nelson, 1969) . Cox regression (Cox, 1972) was used to investigate if the group difference with respect to the local relapse rate remained after adjustment for age, T-stage, N-stage and tumour differentiation.
Results
Amplification of the CCND1 gene in NSCLC Fifty-three patients with operable NSCLC were investigated for CCNDI gene amplification by Southern blotting and multiplex PCR analyses. In 8/53 (15%) of the NSCLC a 3-to 20-fold amplification of the CCNDI gene was identified (5/35 squamous cell, 2/11 adeno-and 1/2 large cell carcinoma, Figure 1 ). This result was confirmed by a PCR multiplex comparing CCNDI amplification with the amplification of the adenosine deaminase gene (chromosome 20ql2-13), and numerical differences in chromosome 11 copy number were excluded by a PCR multiplex, comparing CCNDI with the progesterone receptor gene located on the same arm of chromosome 11 (Figure 1 ). Five patients with amplification were informative for the cyclin DI gene polymorphism (Heighway, 1991) ; allelic imbalance was observed in each case supporting the amplification data obtained by Southern blotting and PCR multiplex.
Immunohistochemistry
The immunohistochemistry was performed as described previously (Gillett et al., 1994) . Briefly, formalin-fixed paraffin sections (4 ,uM) from the 53 primary lung tumours prepared in Berne, 33 in Manchester and 14 breast cancers were air dried on 2% 3-aminopropyltriethoxysilane (APTS) (Sigma, Poole, UK)-coated slides. After dewaxing in xylene, the sections were treated for 15 min with 300 ml methanol and 10 ml hydrogen peroxide in order to block endogenous peroxidase and rinsed thoroughly in water. They were then placed in citrate buffer, boiled twice in a microwave, washed with water and placed in TRIS buffer (pH 7.6). After incubation in 1: 100 goat serum for 20 min at room temperature, they were placed in 1% bovine serum albumin (BSA) and 1:100 monoclonal cyclin DI antibody (Novocastra, Newcastle, England) overnight at room temperature. After two washes with TRIS buffer they were incubated in 1: 100 biotinylated goat anti-mouse/rabbit IG(Dako, Glostrop, Denmark) for 30 min, washed subsequently twice with TRIS, incubated in 1:100 solution of streptavidin-biotin complex for 30 min at room temperature, rewashed in TRIS buffer and placed in diaminobenzene (10 mg 10 ml-') for 10 min, counterstained with haematoxylin, washed in water, cleared, dehydrated and mounted. Cyclin Dl staining was examined according to the intensity of the majority of cells. The slides were assessed blind, and the pathologists did not know the results of the molecular analyses. Positive and negative controls were performed for each tumour series. Two categories of staining were used: nil -weak, and moderate -strong. A tumour was considered positive in the case of a moderate -strong staining. In some cases of negative cyclin DI tumour staining we repeated the analyses in several regions of the tumour. Motokura and Arnold, 1993b; Hunter and Pines, 1994; Sherr, 1995 lanes 1 and 4) , NSCLC DNA (T) (lanes 2, 5, 7) and cDNA (T*) (lanes 3, 6, 8): Lanes 1 -3, 4-6, the amplified allele is overexpressed (both tumours showed nuclear cyclin Dl staining), lanes 7-8, tumour DNA shows no allelic imbalance but transcript levels are clearly imbalanced (cytoplasmic cyclin Dl overexpression); lane 9, phiX174 HaeIII marker (Promega). Zhang et al., 1993; Bartkova et al., 1994 Bartkova et al., , 1995 Gillett et al., 1994) ) in which cyclin Dl was confined to the nucleus, in our study, cyclin DI protein was frequently observed at high levels, and sometimes exclusively, within the cytoplasm of the tumour cells. This finding is in agreement with the very recently published report inhibitor of CDK2) have been reported recently and might explain why some functional experiments have produced paradoxical results (Peters, 1994) . In particular, cyclin Dl overexpression may lead in post-mitotic neurons to apoptosis (Freeman et al., 1994) , and in human diploid fibroblasts it might induce senescence (Dulic et al., 1993; Lucibello et al., 1993) . Allele-specific expression analysis was carried out in the tumours studied. In all RFLP informative cases, in which elevated protein levels were demonstrated, an imbalance in allele-specific relative transcript abundance was seen. Conversely, no tumours scoring negative for cyclin D1 expression by immunostaining displayed an imbalance in transcript levels (except for one tumour with a loss of heterozygosity at the CCNDI locus). These data suggest that overexpression of CCNDI was caused by specific genetic events affecting just one parental allele. Thus, the elevated expression seen in the tumour is not simply a result of non-specific up-regulation of a gene involved in rapid cell growth but is the result of genetic alterations directly affecting CCNDJ. In several cases the transcript imbalance seen in cDNA favoured the nonamplified allele. As the polymorphic restriction site is located distant to the coding sequence, within the long 3'UTR, the most likely explanation for this finding is that the mRNA encoded by the amplified allele is preferentially spliced, precluding amplification of the RFLP site.
The results show an association between cyclin DI overexpression in the primary tumour and a low degree of differentiation, little lymphocytic infiltration of the tumour, and a low incidence of local relapse. Consistent with this result, overexpression of other oncogene products such as the BCL2 protein (Pezzella et al., 1993) , which is known to inhibit programmed cell death and the epidermal growth factor receptor (EGFR) (Lee et al., 1989 ) that mediates the effects of the EGF and transforming growth factor (TGF)-x have been associated with a better patient survival. However, because of the relatively small number of patients in this study, the confidence interval for the local relapse hazard ratio was wide, indicating that these data must be interpreted with caution and require larger studies to confirm the usefulness of cyclin Dl overexpression as a prognostic factor.
